Jun 26, 2024, 12:40
EGFR co-inhibition in KRAS
Megan Barnet, Medical Oncologist at The Kinghorn Cancer Centre, shared on X:
“Great summary from Ryan Corcoran (Mass General Cancer Center) re targeting RAS. Similar single agent ORR G12Cinh PDAC compared with NSCLC, vs CRC which improves with addition anti-EGFR. Supports KRAS good target in PDAC …just need to progress in G12D.”
Source: Megan Barnet/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 14, 2024, 14:12
Sep 14, 2024, 14:02
Sep 14, 2024, 13:51
Sep 14, 2024, 13:51
Sep 14, 2024, 13:46